SeinLwinMD

PubMed

• 5 citations
  Immune cell types involved in early uptake and transport of recombinant mouse prion protein in Peyer’s patches of calves
  Sein Lwin, Yasuo Inoshima, Yasuro Atoji, Hiroshi Ueno, Naotaka Ishiguro> ;Cell and Tissue Research. 2009 Oct 16
• Calmodulin kinase II inhibition disrupts cardiomyopathic effects of enhanced green fluorescent protein.
  Khoo, M. S., Grueter, C. E., Eren, M., Yang, J., Zhang, R., Bass, M. A., Lwin, S. T., Mendes, L. A., Vaughan, D. E., Colbran, R. J., Anderson, M. E.> ;J Mol Cell Cardiol. 2008 Feb
• Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
  Edwards, C. M., Edwards, J. R., Lwin, S. T., Esparza, J., Oyajobi, B. O., McCluskey, B., Munoz, S., Grubbs, B., Mundy, G. R.> ;Blood. 2008 Mar 1
• Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.
  Edwards, C. M., Lwin, S. T., Fowler, J. A., Oyajobi, B. O., Zhuang, J., Bates, A. L., Mundy, G. R.> ;Am J Hematol. 2009 May
• A murine model of myeloma that allows genetic manipulation of the host microenvironment.
  Fowler, J. A., Mundy, G. R., Lwin, S. T., Lynch, C. C., Edwards, C. M.> ;Dis Model Mech. 2009 Sep 26
• Inhibition of TGF-? signaling by 1D11 antibody treatment increases bone mass and quality in vivo.
  Edwards, J. R., Nyman, J. S., Lwin, S. T., Moore, M. M., Esparza, J., O'Quinn, E. C., Hart, A. J., Biswas, S., Patil, C. A., Lonning, S., Mahadevan-Jansen, A., Mundy, ...> ;J Bone Miner Res. 2010 Nov
• Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.
  Fowler, J. A., Lwin, S. T., Drake, M. T., Edwards, J. R., Kyle, R. A., Mundy, G. R., Edwards, C. M.> ;Blood. 2011 Nov 24
• Join now to see all